Tradewinds Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,000
| Closed | -$80K | – | 701 |
|
|
2022
Q1 | $80K | Hold |
1,000
| – | – | 0.01% | 190 |
|
|
2021
Q4 | $77K | Hold |
1,000
| – | – | 0.01% | 202 |
|
|
2021
Q3 | $73K | Hold |
1,000
| – | – | 0.01% | 190 |
|
|
2021
Q2 | $73K | Hold |
1,000
| – | – | 0.01% | 188 |
|
|
2021
Q1 | $69K | Hold |
1,000
| – | – | 0.01% | 191 |
|
|
2020
Q4 | $66K | Hold |
1,000
| – | – | 0.01% | 188 |
|
|
2020
Q3 | $62K | Hold |
1,000
| – | – | 0.01% | 174 |
|
|
2020
Q2 | $62K | Hold |
1,000
| – | – | 0.02% | 172 |
|
|
2020
Q1 | $54K | Hold |
1,000
| – | – | 0.02% | 172 |
|
|
2019
Q4 | $64K | Hold |
1,000
| – | – | 0.02% | 183 |
|
|
2019
Q3 | $57K | Hold |
1,000
| – | – | 0.02% | 165 |
|
|
2019
Q2 | $59K | Hold |
1,000
| – | – | 0.02% | 166 |
|
|
2019
Q1 | $61K | Hold |
1,000
| – | – | 0.02% | 179 |
|
|
2018
Q4 | $55K | Hold |
1,000
| – | – | 0.03% | 181 |
|
|
2018
Q3 | $64K | Hold |
1,000
| – | – | 0.02% | 186 |
|
|
2018
Q2 | $59K | Sell |
1,000
-200
| -17% | -$11.6K | 0.02% | 193 |
|
|
2018
Q1 | $68K | Hold |
1,200
| – | – | 0.03% | 173 |
|
|
2017
Q4 | $71K | Hold |
1,200
| – | – | 0.03% | 172 |
|
|
2017
Q3 | $69K | Hold |
1,200
| – | – | 0.04% | 173 |
|
|
2017
Q2 | $71K | Hold |
1,200
| – | – | 0.04% | 175 |
|
|
2017
Q1 | $66K | Hold |
1,200
| – | – | 0.04% | 171 |
|
|
2016
Q4 | $63K | Hold |
1,200
| – | – | 0.04% | 181 |
|
|
2016
Q3 | $69K | Hold |
1,200
| – | – | 0.05% | 163 |
|
|
2016
Q2 | $70K | Hold |
1,200
| – | – | 0.05% | 169 |
|
|
2016
Q1 | $69K | Hold |
1,200
| – | – | 0.05% | 185 |
|
|
2015
Q4 | $78K | Hold |
1,200
| – | – | 0.06% | 168 |
|
|
2015
Q3 | $76K | Sell |
1,200
-600
| -33% | -$42.2K | 0.06% | 163 |
|
|
2015
Q2 | $127K | Hold |
1,800
| – | – | 0.09% | 135 |
|
|
2015
Q1 | $126K | Sell |
1,800
-200
| -10% | -$13.6K | 0.09% | 141 |
|
|
2014
Q4 | $129K | Sell |
2,000
-120
| -6% | -$7.64K | 0.09% | 137 |
|
|
2014
Q3 | $135K | Sell |
2,120
-160
| -7% | -$9.91K | 0.1% | 132 |
|
|
2014
Q2 | $141K | Sell |
2,280
-120
| -5% | -$7.13K | 0.11% | 127 |
|
|
2014
Q1 | $140K | Hold |
2,400
| – | – | 0.11% | 130 |
|
|
2013
Q4 | $127K | Buy |
+2,400
| New | +$122K | 0.1% | 137 |
|
Other funds holding PPH
PF
NC
NI
LJAC
Tradewinds Capital Management's PPH Position: Q2 2022 in Review
Tradewinds Capital Management sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2022, closing a stake of 1,000 shares — an estimated $80K sold.
Tradewinds Capital Management first reported a position in PPH in Q4 2013 and held it in 34 quarters. The position peaked at $141K in Q2 2014. 91 funds tracked by Wall St. Rank hold PPH as of Q2 2022.
- Tradewinds Capital Management reported no remaining VanEck Pharmaceutical ETF position as of Q2 2022 after selling out during the quarter.
- Tradewinds Capital Management sold 1,000 VanEck Pharmaceutical ETF shares in Q2 2022, an estimated $80K.
- Tradewinds Capital Management first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and held it in 34 quarters.
- Tradewinds Capital Management's VanEck Pharmaceutical ETF position peaked at $141K in Q2 2014.
- 91 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2022.
Based on Tradewinds Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.